Members of ELZA are heavily involved both in clinical, but also in laboratory research. ELZA follows the american model, where advances in medicine do not necessarily have to be initiated at universities only. Rather, small and innovative “think tanks” can, in collaboration with academic institutions, be incubators for translational research.

The patient profits from doctors, that do not only apply the latest developments, but have a deep understanding of them, because they co-developed them.


Current focus of research at ELZA

Currently, ELZA’s research focuses on various topics, both in basic and clinical research.

Basic research

  • Retina

Molecular mechanisms leading to retinal degeneration. In vivo-work in transgenic animal models for retinal degeneration and ex vivo in incubated retinas. Publication of several high-impact papers, including Nature Medicine and Nature Genetics.

  • Cornea

Mechanisms of corneal wound healing after refractive laser surgery. Advancing corneal collagen cross-linking technology. Keratoconus and corneal biomechanics. Scleral cross-linking. Improving PACK-CXL technology for corneal infection.

Clinical research

  • Cornea

Improvement of current ablation algorithms in refractive laser surgery. Establishment of new techniques for the management of complications after refractive laser surgery. Improving the technique of corneal crosslinking (CXL) for the treatment of progressive keratoconus, iatrogenic keratectasia, corneal melting processes and corneal dystrophies.


Scientific publications of ELZA members


Cross-Linking in the USA – Part 3: Off-Label applications

cxl in the usa = oxygen riboflavin
Cross-Linking: Off-label applications Epi-off CXL Cross-linking the cornea ...

Cross-Linking in the USA – Part 4: The Future

Emilio Torres-Netto presenting PACK-CXL trial data at ESCRS 2018 in Vienna
PACK-CXL The process of cross-linking the cornea involves ...

Cross-Linking in the USA – Part 2: Best Practice

ribo-cxl-in-the-usa
Follow best-practice Anaesthesia Topical, usually with tetracaine or ...

Cross-Linking in the USA – Part 1: Patient and Riboflavin Selection

CXL in the USA - Andy Warhol inspired take on the FDA offices
Cross-Linking in the USA Corneal cross-linking (CXL) in ...

ELZA at the CXL Experts Meeting 2018 in Zurich

The Cross-Linking Experts 2018 Meeting 2018 Zurich, organised ...

ELZA at the 2018 ATMO Eye Meeting in Tunisia

ELZA in Tunisia: ELZA founder Farhad Hafezi gives ...

Children: to cross-link or not to cross-link?

Children: to cross-link or not to cross-link?
Children: to cross-link or not to cross-link? If a ...

Cross-Linking in thin corneas: simple, personal and more precise

OCT thin cornea
Keratoconus is the progressive thinning of the cornea, ...
Loading...